Enovix (ENVX) Cash & Equivalents (2020 - 2026)

Enovix's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $88.8 million for Q2 2026.

• Quarterly Cash & Equivalents fell 53.26% year-over-year to $88.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $88.8 million (down 53.26% YoY) and the FY2025 annual result came in at $106.0 million, down 61.15% from the prior year.
• Cash & Equivalents was $88.8 million for Q2 2026 at Enovix, down from $106.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $408.2 million in Q2 2022 and bottomed at $88.8 million in Q2 2026.
• A 5-year average of $265.4 million and a median of $271.8 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 7670.75% — and 2025, when it tumbled 61.15%.
• Enovix's Cash & Equivalents stood at $349.0 million in 2022, then slumped by 33.2% to $233.1 million in 2023, then increased by 17.05% to $272.9 million in 2024, then tumbled by 61.15% to $106.0 million in 2025, then dropped by 16.27% to $88.8 million in 2026.
• Business Quant data shows ENVX's Cash & Equivalents at $88.8 million in Q2 2026, $106.0 million in Q4 2025, and $335.5 million in Q3 2025.